HUM vs HCA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 10, 2026

HUM

50.4
AI Score
VS
HUM Wins

HCA

37.0
AI Score

Investment Advisor Scores

HUM

50score
Recommendation
HOLD

HCA

37score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric HUM HCA Winner
Forward P/E 27.1739 15.7978 HCA
PEG Ratio 1.1953 1.5131 HUM
Revenue Growth 26.1% 3.6% HUM
Earnings Growth -17.9% 4.5% HCA
Tradestie Score 50.4/100 37.0/100 HUM
Profit Margin 0.8% 8.6% HCA
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY HUM

Relative Price Performance (Last 90 Days)

HUM 1M: +4.1% · 3M: +17.1% HCA 1M: +6.5% · 3M: +23.2%

Current Technical Phase

HUM

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.7% over 20 days), RSI 65

RSI (14): 64.6 · Price: $450.00

HCA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (6.2% over 20 days), RSI 61

RSI (14): 61.3 · Price: $499.05

Fundamentals Snapshot

Metric HUM HCA
Market Cap — —
Forward P/E 24.9 16.0
Trailing P/E 43.5 16.6
Revenue (TTM) — —
Revenue Growth 0.3% 0.0%
Gross Margin 0.1% 0.4%
Operating Margin 0.0% 0.2%
EPS 10.19 30.15
Dividend Yield 0.01% 0.01%

Frequently Asked Questions

Based on our detailed analysis, HUM is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.